
Digistain YC 지원서
Digistain은(는) Summer 2021 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.
- YC 배치
- Summer 2021
- 산업
- HealthcareDiagnostics
- 팀 규모
- 40
- 상태
- Active
- 출시됨
- 2021
창업자
Hemmel AmraniaFounder
Chris PhillipsFounder
Digistain의 사업 내용
In the global fight against breast cancer, Digistain stands at the forefront, offering a beacon of hope to millions. Our journey began at Imperial College London, where ground-breaking research gave birth to a technology poised to revolutionize breast cancer diagnostics. The Challenge: Every year, breast cancer affects 2.3 million individuals globally. Post-surgery, 60% of patients are advised to undergo genomic testing, an expensive and time-consuming process monopolized by a single lab in the U.S., costing around $4,000 and taking nearly two months. Consequently, only 5% undergo this vital testing. The rest, unable to access this crucial diagnostic step, often resort to chemotherapy - a treatment that, in one in four cases, is more harmful than the cancer itself. Our Solution: Digistain addresses this critical gap. Our technology transforms the current diagnostic process by enabling hospitals to analyze patient samples in-house using existing equipment, supplemented with our innovative technology. This approach offers near-instantaneous decision-making data, a stark contrast to the existing month-long waits. Central to our technology is a proprietary algorithm that identifies a unique spectral fingerprint of the tumour in the infrared spectrum, providing a personalized risk score. This score guides oncologists in selecting the most effective, individualized treatment plans, potentially reducing unnecessary chemotherapy and its harmful side effects. Impact and Potential: Our solution not only challenges the status quo in technology but also in accessibility. In a landmark government-commissioned study, Digistain demonstrated clinical evidence on par with the market leader, but at a fraction of the cost and time. Already making waves in clinical practice globally, with insurance reimbursement at leading cancer centers, our technology represents a paradigm shift in cancer care. Recognized by the Institute of Physics, the Royal Society, and Imperial College for our innovative contributions, and supported by entities like the NHS, Y Combinator, and the European Investment Bank, Digistain is more than a company - it’s a movement towards equitable, effective cancer treatment. With the potential to democratize access to life-saving diagnostics, Digistain is not just envisioning a better future for cancer patients; we are actively creating it.
Digistain의 YC 지원서, 재구성됨
Y Combinator 지원
Digistain, Summer 2021 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Digistain
Pioneering Breast Cancer Diagnostics
We built a medical device and software that allows hospitals to analyze breast cancer tissue samples on-site. Our product uses infrared spectroscopy combined with a proprietary algorithm to identify a tumour's spectral fingerprint and generate a personalized risk score. This helps oncologists decide on the best treatment quickly, avoiding expensive, slow genomic tests.
We live in London, England, and the company is based here. After YC, we'll continue to operate from London.
We are based in London because our technology originated at Imperial College London, and much of our early clinical work and validation has been done here. Staying close to NHS partners and research institutions is critical for clinical adoption.
전체 지원서에서 21개의 추가 답변
Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.
자주 묻는 질문
Digistain의 실제 YC 지원서인가요?
아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Digistain의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Digistain과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.
Digistain은(는) 어떤 YC 배치에 있었나요?
Digistain은(는) Y Combinator Summer 2021 배치에 참여했습니다.
Digistain은(는) 누가 설립했나요?
Digistain은(는) Hemmel Amrania, Chris Phillips(이)가 설립했습니다.
Digistain은(는) 무엇을 하나요?
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
전체 재구성된 지원서를 어떻게 읽나요?
무료 Round Funded 계정을 만드세요. Digistain의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.